Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine.
about
The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes.How to assess microvascular structure in humans.Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitusVildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study.Retinal Microcirculation in Type 1 Diabetic Patients With and Without Peripheral Sensory Neuropathy.Early Signs of End-Organ Damage in Retinal Arterioles in Patients with Type 2 Diabetes Compared to Hypertensive Patients.Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients.Treatment of arterial remodeling in essential hypertension.Retinal arterial hypertrophy: the new LVH?Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.New Methods to Study the Microcirculation.Residual small artery impairment in hypertensive patients with normal albumin-creatinine ratio.
P2860
Q33942688-3D11D0BE-0B91-4EF6-AAF5-C20F60FC4040Q34143078-B6419673-5FBF-47CE-B515-593B44FC5391Q34188567-42F2C113-36DB-461A-8EDF-9C176D73DAE0Q34658875-665D17DE-2DC8-4BCC-A043-4A04C94FC01FQ35176361-A239B0EC-B045-49FE-8FF6-C73AFEF533FCQ36043226-216C601F-4C56-45B5-B2F5-DFAAF158595CQ36053490-FC2B65B1-6128-4479-9D1D-7547FA7338C7Q38068360-912736D0-C0D9-45E5-BB2F-AA8591273B22Q38098078-1180CF47-95A2-4323-B444-9733D6162CA8Q47102389-1CBFAACE-2954-46C7-81C9-06B270546083Q47261366-EFBAEB9D-4224-453F-8346-8D926DE110FDQ50717199-1D84FC98-75D5-498D-8857-64D3EAAB7F08
P2860
Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Wall-to-lumen ratio of retinal ...... bitor N-monomethyl-L-arginine.
@ast
Wall-to-lumen ratio of retinal ...... bitor N-monomethyl-L-arginine.
@en
type
label
Wall-to-lumen ratio of retinal ...... bitor N-monomethyl-L-arginine.
@ast
Wall-to-lumen ratio of retinal ...... bitor N-monomethyl-L-arginine.
@en
prefLabel
Wall-to-lumen ratio of retinal ...... bitor N-monomethyl-L-arginine.
@ast
Wall-to-lumen ratio of retinal ...... bitor N-monomethyl-L-arginine.
@en
P2093
P1476
Wall-to-lumen ratio of retinal ...... bitor N-monomethyl-L-arginine.
@en
P2093
Christian Ott
Georg Michelson
Joanna M Harazny
Markus P Schlaich
Markus P Schneider
Martin Ritt
Roland E Schmieder
P304
P356
10.1097/HJH.0B013E32833013FD
P577
2009-11-01T00:00:00Z